ロード中...
MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a high-risk head and neck cancer with poor clinical outcomes and insufficient treatments. The mouse double minute 2 homolog (MDM2) is the main molecular target in the clinical treatment of cancer. Indeed, MDM2 negatively regulates p53 through ubiquitin-dependent deg...
保存先:
| 出版年: | Cancer Biol Ther |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783115/ https://ncbi.nlm.nih.gov/pubmed/31311404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1638677 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|